Original InvestigationDistinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry
Central Illustration
Key Words
Abbreviations and Acronyms
Cited by (0)
Funding by the National Heart, Lung, and Blood Institute grant U01HL117006-01A1 (to Drs. Kramer and Neubauer) and the Oxford NIHR Biomedical Research Centre (to Drs. Neubauer and Watkins). Dr. Neubauer has been a consultant for Pfizer and Cytokinetics; and has received research grants from Boehringer Ingelheim. Dr. Ho has been a consultant for and received research support from MyoKardia. Dr. Kwong has received research support from Siemens Healthineers, Bayer AG, and MyoKardia. Dr. DiMarco has been a consultant to Novartis, Celgene, and Daiichi-Sankyo. Dr. Friedrich has been a board member, shareholder, and consultant for Circle Cardiovascular Imaging. Dr. Jarolim has received research support from Abbott Laboratories, AstraZeneca, LP, Daiichi-Sankyo, GlaxoSmithKline, Merck and Co., Roche Diagnostics Corporation, Takeda Global Research and Development Center, and Waters Technologies Corporation; and has received consulting fees from Roche Diagnostics Corporation. Dr. Maron has been a consultant to iRhythm, Celltrion, and Cytokinetics; and has received research support from iRhythm. Dr. Schulz-Menger has been a consultant for Bayer; and has received research grants from Bayer, Siemens Healthineers, and Circle Cardiovascular Imaging. Dr. Piechnik has patent authorship rights for a U.S. patent held by Siemens Healthcare and managed by Oxford University Innovations. Dr. Watkins has been a consultant for Cytokinetics. Dr. Weintraub has been a consultant for Amarin, Janssen, AstraZeneca, and SC Pharma; and has received research grants from Amarin. Dr. Kramer has been a consultant for Cytokinetics; and has received research grants from Biotelemetry and MyoKardia. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. P.K. Shah, MD, served as Guest Editor-in-Chief for this paper.